Commission Implementing Decision (EU) 2026/2121 of 23 September 2026 renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2026) 6605)

Commission Implementing Decision (EU) 2015/683 (2) authorised the placing on the market of food and feed containing, consisting of or produced from genetically modified maize MON 87460. The scope of that authorisation also covered the placing on the market of products other than food and feed containing or consisting of genetically modified maize MON 87460, for the same uses as any other maize, with the exception of cultivation.

On 11 March 2024, Bayer Agriculture BV, based in Belgium, submitted on behalf of Bayer CropScience LP, based in United States (‘the applicant’), an application to the Commission for renewal of that authorisation.

On 8 December 2025, the European Food Safety Authority (‘the Authority’) published a favourable scientific opinion on the assessment of genetically modified maize MON 87460 for the renewal authorisation (3). It concluded that the renewal application did not contain evidence of any new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on genetically modified maize MON 87460, published by the Authority in 2012 (4).

In its scientific opinion, the Authority considered all the questions and concerns raised by the Member States in the context of the consultation with the national competent authorities as provided for in Article 6(4) and Article 18(4) of Regulation (EC) No 1829/2003.

The Authority also concluded that the monitoring plan for the environmental effects, consisting of a general surveillance plan, submitted by the applicant, is in line with the intended uses of the products containing or consisting of genetically modified maize MON 87460.

Taking into account the Authority’s conclusions, the authorisation for the placing on the market of food and feed containing, consisting of or produced from genetically modified maize MON 87460 and of products containing it or consisting of it for uses other than food and feed, with the exception of cultivation, should be renewed.

By letter of 19 January 2026, Bayer Agriculture BV, based in Belgium, informed the Commission that Bayer CropScience LP converted its legal form and changed its name to Bayer CropScience LLC as of 1 January 2026.

A unique identifier was assigned to genetically modified maize MON 87460, pursuant to Commission Regulation (EC) No 65/2004 (5), in the context of its initial authorisation by Decision (EU) 2015/683. That unique identifier should continue to be used.

As regards the products covered by this Decision, no specific labelling requirements, other than those provided for in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003 of the European Parliament and of the Council (6), appear to be necessary. However, in order to ensure that the use of products containing or consisting of genetically modified maize MON 87460 remains within the limits of the authorisation granted by this Decision, the labelling of such products, with the exception of food and food ingredients, should contain a clear indication that they are not intended for cultivation.

The authorisation holder should submit annual reports on the implementation and on the results of the activities set out in the monitoring plan for environmental effects. Those results should be presented in accordance with the requirements laid down in Commission Decision 2009/770/EC (7).

The opinion of the Authority does not justify the imposition of specific conditions or restrictions for the placing on the market, for the use and handling, including post-market monitoring requirements regarding the consumption of food and feed containing, consisting of or produced from genetically modified maize MON 87460, or for the protection of particular ecosystems, the environment or geographical areas, as provided for in Article 6(5), point (e), and Article 18(5), point (e) of Regulation (EC) No 1829/2003.

All relevant information on the authorisation of the products covered by this Decision should be entered in the Community register of genetically modified food and feed referred to in Article 28(1) of Regulation (EC) No 1829/2003.

This Decision is to be notified through the Biosafety Clearing-House to the Parties to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity, pursuant to Article 9(1) and Article 15(2), point (c), of Regulation (EC) No 1946/2003 of the European Parliament and of the Council (8).

The Standing Committee on Plants, Animals, Food and Feed has not delivered an opinion within the time limit laid down by its Chairman. This implementing act was deemed to be necessary and the chair submitted it to the appeal committee for further deliberation. The appeal committee did not deliver an opinion,